108 related articles for article (PubMed ID: 19369964)
1. Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo.
Qian Z; Mao L; Fernald AA; Yu H; Luo R; Jiang Y; Anastasi J; Valk PJ; Delwel R; Le Beau MM
Leukemia; 2009 Sep; 23(9):1650-7. PubMed ID: 19369964
[TBL] [Abstract][Full Text] [Related]
2. FHL2 regulates hematopoietic stem cell functions under stress conditions.
Hou Y; Wang X; Li L; Fan R; Chen J; Zhu T; Li W; Jiang Y; Mittal N; Wu W; Peace D; Qian Z
Leukemia; 2015 Mar; 29(3):615-24. PubMed ID: 25179730
[TBL] [Abstract][Full Text] [Related]
3. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
Govoni KE; Baylink DJ; Chen J; Mohan S
Calcif Tissue Int; 2006 Aug; 79(2):112-7. PubMed ID: 16927043
[TBL] [Abstract][Full Text] [Related]
4. The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b.
Brun J; Fromigué O; Dieudonné FX; Marty C; Chen J; Dahan J; Wei Y; Marie PJ
Bone; 2013 Mar; 53(1):6-12. PubMed ID: 23201222
[TBL] [Abstract][Full Text] [Related]
5. Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.
König K; Diehl L; Rommerscheidt-Fuss U; Golletz C; Quast T; Kahl P; Kolanus W; Knolle P; Buettner R; Heukamp LC
J Immunol; 2010 Aug; 185(3):1466-75. PubMed ID: 20592280
[TBL] [Abstract][Full Text] [Related]
6. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
[TBL] [Abstract][Full Text] [Related]
7. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
8. FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1.
Sun J; Yan G; Ren A; You B; Liao JK
Circ Res; 2006 Sep; 99(5):468-76. PubMed ID: 16888242
[TBL] [Abstract][Full Text] [Related]
9. A novel colon cancer gene therapy using rAAV‑mediated expression of human shRNA-FHL2.
Wu Y; Guo Z; Zhang D; Zhang W; Yan Q; Shi X; Zhang M; Zhao Y; Zhang Y; Jiang B; Cheng T; Bai Y; Wang J
Int J Oncol; 2013 Nov; 43(5):1618-26. PubMed ID: 24008552
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
[TBL] [Abstract][Full Text] [Related]
11. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
Li M; Wang J; Ng SS; Chan CY; Chen AC; Xia HP; Yew DT; Wong BC; Chen Z; Kung HF; Lin MC
Glia; 2008 Sep; 56(12):1328-38. PubMed ID: 18615633
[TBL] [Abstract][Full Text] [Related]
12. Deficiency in the LIM-only protein Fhl2 impairs skin wound healing.
Wixler V; Hirner S; Müller JM; Gullotti L; Will C; Kirfel J; Günther T; Schneider H; Bosserhoff A; Schorle H; Park J; Schüle R; Buettner R
J Cell Biol; 2007 Apr; 177(1):163-72. PubMed ID: 17420295
[TBL] [Abstract][Full Text] [Related]
13. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the FHL2 gene attenuates the formation of atherosclerotic lesions after a cholesterol-enriched diet.
Chu PH; Yeh HI; Wu HH; Hong RC; Shiu TF; Yang CM
Life Sci; 2010 Feb; 86(9-10):365-71. PubMed ID: 20096293
[TBL] [Abstract][Full Text] [Related]
15. Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins.
Park J; Will C; Martin B; Gullotti L; Friedrichs N; Buettner R; Schneider H; Ludwig S; Wixler V
FASEB J; 2008 Jul; 22(7):2508-20. PubMed ID: 18356303
[TBL] [Abstract][Full Text] [Related]
16. LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cells.
Zienert E; Eke I; Aust D; Cordes N
Cancer Lett; 2015 Aug; 364(1):17-24. PubMed ID: 25917075
[TBL] [Abstract][Full Text] [Related]
17. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
[TBL] [Abstract][Full Text] [Related]
18. [Mapping of FHL2 transcription activation domain].
Yan JH; Ye QN; Fang Y; Zhu JH; Huang CF
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):643-8. PubMed ID: 12883635
[TBL] [Abstract][Full Text] [Related]
19. LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression.
Dahan J; Levillayer F; Xia T; Nouët Y; Werts C; Fanton d'Andon M; Adib-Conquy M; Cassard-Doulcier AM; Khanna V; Chen J; Tordjmann T; Buendia MA; Jouvion G; Wei Y
Mol Cell Biol; 2017 May; 37(10):. PubMed ID: 28223370
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of the expression of FHL2 by RNA interference].
Wang ZY; Zhou L; Ding LH; Lv QJ; Yang X; Ye QN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1149-51. PubMed ID: 21055355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
